Latest News

  • Alkermes Announces Launch of 3rd Annual Alkermes Pathways Research Awards® Program Read More
  • Alkermes Awards COVID-19 Relief Fund Grants to 10 Innovative Programs Designed to Address Challenges for Patient Communities Read More
  • New Preclinical Data on ALKS 4230 in Combination With Lucitanib to be Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II Read More
  • Alkermes to Take Part in 41st Annual Goldman Sachs Global Healthcare Conference Read More

Investors

Response to Current Events